Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission.
about
Antiretroviral interventions for preventing breast milk transmission of HIVAntiretroviral drug regimens to prevent mother-to-child transmission of HIV: a review of scientific, program, and policy advances for sub-Saharan AfricaEarly infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions.Safety and effectiveness of combination antiretroviral therapy during the first year of treatment in HIV-1 infected Rwandan children: a prospective studyIf you text them, they will come: using the HIV infant tracking system to improve early infant diagnosis quality and retention in Kenya.Initiation of antiretroviral treatment in women after delivery can induce multiclass drug resistance in breastfeeding HIV-infected infants.Use of dried-blood-spot samples and in-house assays to identify antiretroviral drug resistance in HIV-infected children in resource-constrained settingsAnalysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis.Improving early infant HIV diagnosis in Kenya: study protocol of a cluster-randomized efficacy trial of the HITSystem.Treatment Outcomes and Resistance Patterns of Children and Adolescents on Second-Line Antiretroviral Therapy in AsiaEfficacy of Six-Week Extended-Dose Nevirapine Varies by Infant Birth Weight with Greatest Relative Efficacy in Low Birth Weight Infants.Cost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in ZimbabweEmerging antiretroviral drug resistance in sub-Saharan Africa: novel affordable technologies are needed to provide resistance testing for individual and public health benefits.Evolving uses of oral reverse transcriptase inhibitors in the HIV-1 epidemic: from treatment to preventionEarly short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaquesWhat is needed to eliminate new pediatric HIV infections: the contribution of model-based analyses.Impact of maternal and infant antiretroviral drug regimens on drug resistance in HIV-infected breastfeeding infants.Switching to Efavirenz Versus Remaining on Ritonavir-boosted Lopinavir in Human Immunodeficiency Virus-infected Children Exposed to Nevirapine: Long-term Outcomes of a Randomized Trial.Persistence of HIV drug resistance among South African children given nevirapine to prevent mother-to-child-transmission.HIV antiretroviral resistance and transmission in mother-infant pairs enrolled in a large perinatal study.
P2860
Q22252958-26A6A288-AFB4-4AD3-9BCB-221DAE25AA30Q27014960-034B8AEC-187B-4DB6-AAA7-E6A3AAE7C231Q33907111-D7AD1363-368B-4BFD-A18E-1AF2628E231BQ34445856-AF057143-B7C9-4D55-81B7-34CEBE052468Q34480976-FCBDFB6C-2FAF-4850-8E5D-563285BF8821Q34756810-5400C3EB-AC71-4450-9898-EA933D6C1FB1Q35598943-7E367864-3B87-437D-B63A-1387A7299A95Q35682303-59772B41-24F6-400B-95AB-1DB80BDBA7BBQ35834452-AAAFBBDA-57BC-48FC-B6F2-11EA6D5F647BQ36063912-35E22E37-7BD1-46BC-848B-E60128F4304CQ36149804-41D73B59-D94E-4CD9-A49D-284A7F32916CQ36517778-349C18CD-7D4F-4CC3-80D7-A7EC35819981Q36669337-3CDE57AC-2DB4-4E7C-AD5C-EA97F083FB3FQ37071435-3652E0DE-84FE-4E1A-AA34-05F3CACE6184Q37171570-70C8B446-FAD3-403B-ABFB-EF5C548CF84CQ37238095-2735C34A-0C2F-492B-84C9-0BB17865F023Q37304975-A2C50017-93B0-4D7F-9790-F10EAC04D303Q40238381-9C5BE388-575E-43E4-A08E-583AB47DB995Q40291462-819075D3-31FD-4DB7-A3F0-D39CAF772915Q49617530-E12532AF-EDE9-41F4-AF7E-AB494ED3F2F1
P2860
Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Slower clearance of nevirapine ...... her-to-child HIV transmission.
@ast
Slower clearance of nevirapine ...... her-to-child HIV transmission.
@en
type
label
Slower clearance of nevirapine ...... her-to-child HIV transmission.
@ast
Slower clearance of nevirapine ...... her-to-child HIV transmission.
@en
prefLabel
Slower clearance of nevirapine ...... her-to-child HIV transmission.
@ast
Slower clearance of nevirapine ...... her-to-child HIV transmission.
@en
P2093
P2860
P356
P1476
Slower clearance of nevirapine ...... her-to-child HIV transmission.
@en
P2093
Abdulhamid Isehak
Abubaker Bedri
Aida Abashawl
Andrea Ruff
Anitha Moorthy
Berhanu Gudetta
Carrie Ziemniak
Deborah Persaud
Elham Hassen
Ethiopian Swen Study Team
P2860
P304
P356
10.1089/AID.2010.0346
P50
P577
2011-02-25T00:00:00Z